Analysis of a Plasmodium falciparum EBA-175 peptide with high binding capacity to erythrocytes and their analogues using 1H NMR

Journal of Structural Biology

Volumn 141, Issue 2, 2003, Pages 115-121

  Cifuentes, Gladys ^a   Guzmán, Fanny ^a   Alba, Martha Patricia ^a   Salazar, Luz Mary ^a   Patarroyo, Manuel Elkin ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Malaria; Peptide; Synthetic vaccine; Three dimensional structure

Indexed keywords

BINDING PROTEIN; ERYTHROCYTE BINDING PROTEIN 175; HIGH BINDING ACTIVITY PEPTIDE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL MODEL; ANTIGENICITY; AOTUS; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ERYTHROCYTE; IMMUNE SYSTEM; IMMUNOGENICITY; MALARIA; MONKEY; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE;

PLASMODIUM FALCIPARUM;

EID: 0037292029     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-8477(02)00584-1     Document Type: Article

References (22)

1. Baker B.M., Gagnon S.J., Biddison W.E., Willey D.C. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling. Immunity. 13:2000;475-484.
2. Bax A., Davis D.G. MLEV-17 based two dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65:1985;355-360.
3. Camus D., Hadley T.J. A Plasmodiun falciparum antigen that binds to host erythrocytes and merozoites. Science. 230:1985;553-556.
4. 1t Mol. Biochem. Parasitol. 85:1997;255-258.
5. Fazekas de.St.G., Webster R.G. Disquisitions of original antigenic Sin. I. Evidence in man. J. Exp. Med. 124:1966;331-345.
6. Houghten R.A. General method for the rapid solid phase synthesis of large numbers of peptides: specificity of antigen antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA. 82:1985;5131-5135.
7. Jeener J., Meier B.H., Backman P., Ernst R.R. Investigation of enhance processes by two dimensional NMR spectroscopy. J. Chem. Phys. 71:1979;4546-4553.
8. Kain K.C., Orlandi P.A., Haynes J.D., Sim K.L., Lanar D.E. Evidence for two stage binding by the 175. kDa erythrocyte binding antigen of P. falciparum J. Exp. Med. 178:1993;1497-1505.
9. Kraj P., Pacholczyk R., Ignatowicz H., Kisielow P., Jensen P., Ignatowicz L. Positive selection of CD4 (+) T cells is induced in vivo by agonist and inhibited by antagonist peptides. J. Exp. Med. 194:2001;407-416.
10. Lambros C., Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocyte stages in culture. J. Parasitol. 65:1979;418-420.
11. Laskowsky R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:1993;283-291.
12. March K. Malaria a neglected disease? Parasitology. 104:1992;S53-S69.
13. 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117:1983;479-485.
14. Richie T.L., Saul A. Progress and challenges for malaria vaccines. Nature. 415:2002;694-701.
15. Rodríguez L.E., Urquiza M., Ocampo M., Suárez J., Curtidor H., Guzmán F., Vargas L.E., Triviños M., Rosas M., Patarroyo M.E. Plasmodium falciparum EBA-175. kDa. protein peptides which bind to human red blood cells Parasitology. 120:2000;225-235.
16. Rodríguez R., Moreno A., Guzmán F., Calvo M., Patarroyo M.E. Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 43:1990;339-354.
17. Sim B.K., Orlandi P.A., Haynes D.J., Klotz F.W., Carter J.M., Camus D., Zegans M.E., Chulay J.D. Primary structure of the 175 Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J. Cell. Biol. 111:1990;1877-1884.
18. Sim B.K., Chitnis C.E., Wasniowska K., Hadley T.J., Miller L.H. Receptor and ligand domains for invasión of erythrocytes by P. falciparum. Science. 264:1994;1941-1944.
19. Slansky J.E., Rattis F.M., Boyd L.F., Famhy T., Jaffe E.M., Schenk J.P., Margulies D.H., Pardoll D.M. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity. 13:2000;529-538.
20. Tangri S., Ishioka G.H., Huang X., Sidney J., Southwood S., Fikes J., Sette A. Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide. J. Exp. Med. 194:2001;833-846.
21. Tian J.H., Miller L.H., Kaslow D.C., Ahlers J., Good M.F., Alling D.W., Berzofsky J.A., Kumar S. Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J. Immunol. 157:1996;1176-1183.
22. Wüthrich K. NMR of proteins and Nucleic Acids. 1986;Wiley, New York.